RenJi Hospital: Neoplasms trials

The registry lists 10 Neoplasms studies with RenJi Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 5Phase 3 1Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase II Prospective Cohort Study of Intravesical Recombinant Human Type 5 Adenovirus Injection for Treatment of High-Risk Non-Muscle Invasive Bladder Cancer: Evaluating Efficacy and SafetyNot yet recruitingNCT07356791Phase 2
• A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral ResectionNot yet recruitingNCT07142200Phase 2
• Target-specific immunoPET Imaging of Digestive System CarcinomaRecruitingNCT06715839Not applicable
• CD70-targeted immunoPET Imaging of Kidney CancerRecruitingNCT06680089Phase 2
• Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder CancerNot yet recruitingNCT06276153
• Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in ChinaCompletedNCT06717178
• Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After ChemotherapyStatus unknownNCT05322187Phase 2/3
• Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsStatus unknownNCT05068180Phase 4
• Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)Status unknownNCT04922047Phase 1/2
• The Role of ctDNA and PBMC in Treatment of Biliary Tract CancerStatus unknownNCT02809898